Matthew Mossanen MD, MPH
Assistant Professor of Surgery, Harvard Medical School, Brigham and Women's Hospital, Division of Urology, Boston, MassachusettsDr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and he received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.
His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer
Recent Contributions to PracticeUpdate:
- Pattern of Adverse Events With New Immuno-Oncology Agents: Implications for Monitoring
- AACR: Combination Checkpoint Inhibitor and Chemotherapy for Advanced Urothelial Carcinoma
- Practical Approaches to BCG Unresponsive Bladder Cancer
- Integrating Immuno-Oncology and Targeted Therapy for Bladder Cancer in Practice
- Smoking Cessation and Bladder Cancer
- Atezolizumab and Bevacizumab for Renal Cell Carcinoma With Variant Histology
- Management Strategies for Non-Muscle-Invasive Bladder Cancer
- Surgical Approaches in Bladder Cancer: Robotic vs Open Cystectomy
- Urinary Diversion in Bladder Cancer and Quality-of-Life Considerations
- Salvage vs Adjuvant Therapy in High-Risk Prostate Cancer